Actualités

Experts at the ESC Cardio-Oncology Congress 2026 highlight the need for prevention, advanced cardiac imaging, mental health support, and integrated survivorship care to protect cancer patients from cardiovascular disease. The RESILIENCE Multi-Stakeholder Meeting, held during the ESC Cardio-Oncology Congress 2026 in Vienna, convened cardiologists, oncologists, hematologists, researchers, industry leaders, regulators,

As part of the Madrid Science and Innovation Week, the RESILIENCE H2020 project invites young people aged 14 to 18 to participate in a free workshop exploring the fascinating connection between heart health and cancer. Through this educational activity, participants will discover how cardiovascular diseases and cancer are linked, and

Join us at the leading European meeting in cardio‑oncology, held within the Cardio Oncology Congress 2026 in Vienna. On 19 June 2026, the European Society of Cardiology (ESC), through the ESC Council of Cardio‑Oncology, will host the second multi‑stakeholder meeting of the EU‑funded RESILIENCE project, supported by the European Commission.

On February 11, the RESILIENCE project took part in the celebration of the International Day of Women and Girls in Science at the Spanish National Center for Cardiovascular Research (CNIC). The event, titled “Let’s Talk About Science: Conference and Panel Discussion,” invited students to discover what scientific research looks like

Every month, we publish an article in the Blog section of our website with a topic we believe may be of interest to the participants in our RESILIENCE clinical trial, patients, family members, friends, and anyone interested in protecting cardiovascular health in relation to cancer. Since the launching of the

An international meta-analysis led by CNIC and published in The New England Journal of Medicine confirms that beta-blockers provide no clinical benefit in patients who have suffered a heart attack and maintain normal cardiac function (LVEF ≥ 50%). The study analyzed individual data from 17,801 patients included in five clinical